Acute Care Diagnostics - Partnership Meeting Breakout Session

The Acute Care Diagnostics (ACD) Breakout Sessions on 24th and 25th May at the 9th EEMEA Partnership Meeting witnessed an inspiring display of collaboration and shared vision as the Distribution Partners from all the three business lines gathered together – Blood Gas, Patient Blood Management and Whole Blood Hemostasis.

On 24th May, after celebrating the successful performance of ACD business in FY2022 and the growth streak of 2023YTD in the key focus areas, the highlight of the afternoon was the ‘Sharing Experiences and Best Practices’ session. This session provided valuable insights into local market dynamics, customer preferences, and successful sales approaches. The knowledge exchange fostered a sense of camaraderie among the attendees, inspiring them to join and support the collective accelerated learning. Johanna Arjanheimo from Mediq Finland shared the collaborative process of winning the Nordlab blood gas tender adding her Finnish humour :-). Mohammed Nafady from AFMS in Saudi Arabia walked us through the well-designed awareness and education campaign on Patient Blood Management in the Kingdom. Andrzej Stephinski then demonstrated the real cases of implementing value and strategic selling in replacing low priced competitors with Hemochron Signature Elite systems. The room was in awe after the eye-opening presentation of Xavier Coll from Werfen in Iberia on the implementation of the ACD portfolio in the Cardiovascular Operating Room (CVOR). Richard Lowndes then shared the key role of connectivity with GEMweb Plus and GEMweb Live as an integral part of ACD strategy at Werfen in the UK. Finally, Ahmed Soliman from Medtech in Qatar shared the successful growth of ACD business at Hamad Medical Corporation.

acd 2

In the morning of 25th May, we started with an engaging workshop session on Competition and the CVOR Customer Journey. EEMEA team together with Adriano Ciccomancini from the Blood Gas Strategic Business Unit at the Bedford technology Center supported EEMEA team guiding the groups to share the key success factors that set apart Werfen ACD solutions from the competitors. The interactions played a pivotal role in ensuring that our offerings resonate with the diverse needs of healthcare professionals and patients.

acd 3

acd 4

The meeting concluding with the much-awaited ACD New Product Launch sessions. The Commercial launch of the GEM Premier ChemSTAT was kicked off with great enthusiasm with product presentations and positioning. Dr. Antonio Leon from Macarena University Hospital in Spain shared with scientific evidence, the pressing need of Basic Metabolic Panel testing in crowded Emergency Departments. After the successful controlled release in Greece, Nikolas Simos from Antisel shared the strategy and insights from the happy customers at Attikon and Nikaia hospital Emergency Departments. Finally, the day was wrapped up with the Controlled Release update and sharing experiences on GEMwebLive and GEM Hemochron 100 by the EEMEA ACD Team.

acd 5

acd 6

Above all the business updates, the best part of the meeting was re-connecting with the colleagues and partners and enjoying the experience of being all together in person! Looking forward to the next one…

Acute Care Diagnostics Marketing Team, EEMEA

Last modified on Thursday, 08 June 2023 06:17

 

All rights reserved. © werfen.com

Get in touch

with the EEMEA team:

eemea@werfen.com

 

werfenplain

Issues

Go to top